PSTX (Poseida) Gross Profit Margin

Corporate emblem and logo of Poseida Corp (PSTX)

The use of the PiggyBac system creates a technological advantage for Poseida Therapeutics (PSTX) in pricing power, although geopolitical risks and sanctions are weighing on logistics. The gross profit margin clearly demonstrates the impact of these factors, where 96.40 becomes the new value of the metric. Rate stability is supported by the full capacity of its own R&D centers and the engagement of certified contractors for vector production.

PSTX - Poseida Gross Margin over the range 07/04/2022 - 01/18/2025

Comprehensive metric breakdowns and analytics for Poseida (PSTX)

Fundamental valuation:Poseida Therapeutics, Inc. (PSTX)
Manufactured products of Poseida Therapeutics Inc

The complex logistics of gene therapy involving liquid nitrogen directly impact the cost of goods sold for Poseida Therapeutics (PSTX). Gross margin measures the portion of revenue remaining after deducting all direct production costs, allowing for an assessment of the company's operational model efficiency. Analyzing this metric via the gross margin chart on GURU.Markets helps investors determine the real profitability of the business, stripped of accounting anomalies.